Bespoke Extracts Reports Q1 2025 Financial Results, Strategic Rebranding

*AURORA, Colo. —* Bespoke Extracts Inc., a Colorado-based company operating
in the regulated cannabis markets in the United States, reported its
financial results for the first quarter ended March 31, 2025.
Financial Highlights for Q1 2025

Revenue Growth: Sales increased to $263,159, up 1.0% from $260,428 in Q1
2024, fueled by strong direct sales of branded pre-rolled joints and
expanded joint production services for licensed dispensaries in Colorado.

Improved Gross Profit: Gross profit rose to $110,779 from $102,581 in Q1
2024, driven by enhanced production efficiencies in pre-rolled joints,
though partially offset by higher packaging and testing costs for new
product launches.

Reduced Operating Expenses: Operating expenses fell to $356,117 from
$405,384 in Q1 2024, reflecting lower stock-based compensation, reduced
salaries, and decreased professional fees.

Reduced Net Loss: Net loss decreased to $260,521, from $314,118 in Q1 2024.
Strategic Rebranding and Product Expansion under The Joint Company

In Q1 2025, Bespoke Extracts rebranded as The Joint Company (TJC), a
pivotal step in its growth strategy. TJC scaled its white-label processing
business and launched two new branded products, Doobskis and Dutch Blunts,
which have gained significant traction in Colorado’s regulated cannabis
market. The Fresh Joint product line continues to increase product revenue,
primarily through growth in multi-packs.
Operational Highlights

Through its subsidiary, Bespoke Extracts Colorado LLC, the Company operates
a marijuana-infused products manufacturing facility in Aurora, selling its
products and services to licensed dispensaries in Colorado.

Achieved cost efficiencies in raw materials, packaging, and labor, boosting
gross margins despite increased marketing and sampling costs for new
product launches.

Daily pre-roll production increased by 32% compared to Q1 2024, enhancing
TJC’s ability to offer competitive processing services and lower priced
products in Colorado.

The Company is exploring expansion of TJC into other state-regulated
cannabis markets, leveraging its successful Colorado operations experience
to pursue new growth opportunities.

Management is focused on expanding market share and optimizing operations
for sustainable, long-term growth.
Management Commentary

Michael Feinsod, CEO, stated: “Q1 2025 marked a transformative period for
Bespoke Extracts as we rebranded to The Joint Company and introduced
Doobskis and Dutch Blunts. These initiatives, combined with enhanced
third-party processing capabilities, have significantly strengthened our
market position and revenue potential. Despite an 8.8% contraction in
Colorado’s regulated cannabis market during the quarter ending March 31,
2025 compared to Q1 2024, we achieved year-over-year growth. Our improved
manufacturing processes are delivering strong results, and we expect
continued gross margin improvements as we scale. We remain committed to
disciplined financial management and strategic expansion in the regulated
cannabis market.”
Fiscal Q2 2025 Outlook

Revenue Growth: Based on preliminary Q2 2025 sales data, the Company
projects revenue exceeding $385,000 for the quarter ending June 30, 2025,
compared to $278,163 in the quarter ended June 30, 2024, driven by
continued growth of FreshJoints, strong demand for Doobskis and Dutch
Blunts and expanded third-party processing services.

Operational Efficiencies: Continued improvements in manufacturing processes
are expected to support higher production volumes and consistent product
quality.

Gross Margin Improvement: Enhanced production efficiencies and cost
management in raw materials, packaging, and labor are projected to drive
higher gross margins, despite increased marketing investments for new
product launches.
About Bespoke Extracts Inc.

Bespoke Extracts Inc. is a Nevada corporation operating in the regulated
cannabis markets in the United States. Through its wholly-owned subsidiary,
Bespoke Extracts Colorado LLC, the Company operates a marijuana-infused
products manufacturing facility in Aurora, Colorado, focusing on delivering
high-quality products to licensed dispensaries under its rebranded
portfolio, The Joint Company.